Frontiers Association of Lipoprotein(a)-Associated Mortality and the Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary Angiography: A 51,500 Cohort Study

Por um escritor misterioso
Last updated 16 julho 2024
Frontiers  Association of Lipoprotein(a)-Associated Mortality and the  Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary  Angiography: A 51,500 Cohort Study
Frontiers  Association of Lipoprotein(a)-Associated Mortality and the  Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary  Angiography: A 51,500 Cohort Study
Frontiers Serum lipoprotein (a) associates with the risk of renal function damage in the CHCN-BTH Study: Cross-sectional and Mendelian randomization analyses
Frontiers  Association of Lipoprotein(a)-Associated Mortality and the  Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary  Angiography: A 51,500 Cohort Study
Frontiers Association of Lipoprotein(a)-Associated Mortality and the Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary Angiography: A 51,500 Cohort Study
Frontiers  Association of Lipoprotein(a)-Associated Mortality and the  Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary  Angiography: A 51,500 Cohort Study
Lipoprotein(a) plasma levels are not associated with survival after acute coronary syndromes: An observational cohort study
Frontiers  Association of Lipoprotein(a)-Associated Mortality and the  Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary  Angiography: A 51,500 Cohort Study
Lipoprotein(a) and Risk of Myocardial Infarction and Death in Chronic Kidney Disease
Frontiers  Association of Lipoprotein(a)-Associated Mortality and the  Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary  Angiography: A 51,500 Cohort Study
Kaihong Chen's research works Tsinghua University, Beijing (TH) and other places
Frontiers  Association of Lipoprotein(a)-Associated Mortality and the  Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary  Angiography: A 51,500 Cohort Study
Frontiers Coronary Artery Disease: Optimal Lipoprotein(a) for Survival—Lower Is Better? A Large Cohort With 43,647 Patients
Frontiers  Association of Lipoprotein(a)-Associated Mortality and the  Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary  Angiography: A 51,500 Cohort Study
Frontiers Does Diabetes Mellitus Increase the Short- and Long-Term Mortality in Patients With Critical Acute Myocardial Infarction? Results From American MIMIC-III and Chinese CIN Cohorts
Frontiers  Association of Lipoprotein(a)-Associated Mortality and the  Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary  Angiography: A 51,500 Cohort Study
Moderately elevated lipoprotein (a) levels are associated with an earlier need for percutaneous coronary intervention in recurrent cardiovascular disease
Frontiers  Association of Lipoprotein(a)-Associated Mortality and the  Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary  Angiography: A 51,500 Cohort Study
Does Diabetes Mellitus Increase the Short- and Long-Term Mortality in Patients With Critical Acute Myocardial Infarction? Results From American MIMIC-III and Chinese CIN Cohorts - Frontiers
Frontiers  Association of Lipoprotein(a)-Associated Mortality and the  Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary  Angiography: A 51,500 Cohort Study
Lipoprotein(a) and Risk of Myocardial Infarction and Death in Chronic Kidney Disease
Frontiers  Association of Lipoprotein(a)-Associated Mortality and the  Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary  Angiography: A 51,500 Cohort Study
The Remnant Lipoprotein Hypothesis of Diabetes-Associated Cardiovascular Disease

© 2014-2024 zilvitismazeikiai.lt. All rights reserved.